Cardinal Health to build pharma distribution plant in Indianapolis
Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis.| Pharmaceutical Processing World
AbbVie (NYSE:ABBV) announced that it began construction for a $70 million expansion of its bioresearch center (ABC) in Worcester, Massachusetts. The ABC in Worcester serves as a center of excellence for biologics R&D and manufacturing. AbbVie said its latest expansion comes as part of a plan to invest more than $10 billion in the U.S.… The post AbbVie invests $70M in U.S. biologics manufacturing, R&D expansion appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis.| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The planned next-generation synthetic medicine active pharmaceutical product (API) facility marks the second of four new sites Lilly plans to announce this year. It follows the announcement of a $5 billion manufacturing facility… The post Lilly to build new $6.5B API manufacturing plant in Texas appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia.| Pharmaceutical Processing World
Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in… The post Gilead breaks ground on California manufacturing hub appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility… The post Thermo Fisher completes acquisition of Sanofi’s fill-finish, packaging site in New Jersey appeared fir...| Pharmaceutical Processing World
Eli Lilly's investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020.| Pharmaceutical Processing World
Purdue University, Eli Lilly and Merck have launched the Young Institute Pharmaceutical Manufacturing Consortium.| Pharmaceutical Processing World
